NCT07392684 Optimisation of the Blood Culture Pathway Utilising Behaviour Change
| NCT ID | NCT07392684 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gloucestershire Hospitals NHS Foundation Trust |
| Condition | Microbiology |
| Study Type | OBSERVATIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 24 participants in total. It began in 2025-10-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Blood culture (BC) is the gold standard for the definitive diagnosis of bacteraemia, providing the opportunity to recover and identify the causative organism, and optimize subsequent antimicrobial treatment. Detection of bacteraemia is critical for the management of sepsis. This study aims to examine the performance of the blood culture pathway in Gloucestershire Hospitals Trust using data analysis, questionnaires and focus groups. . Information collected will be used to design interventions that could be used to optimise the blood culture pathway
Eligibility Criteria
Inclusion Criteria: Secondary data: \- adult blood culture sets received in the microbiology laboratory, between February 2023 and April 2024. Staff member participants \- Staff members that collect adult blood cultures within the Trust Exclusion Criteria: Secondary data: * paediatric blood culture samples * samples where volume, collection and/or time to incubation data are not recorded on laboratory system and/or blood culture analyser
Frequently Asked Questions
Who can join the NCT07392684 clinical trial?
This trial is open to participants of all sexes, studying Microbiology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07392684 currently recruiting?
Yes, NCT07392684 is actively recruiting participants. Visit ClinicalTrials.gov or contact Gloucestershire Hospitals NHS Foundation Trust to inquire about joining.
Where is the NCT07392684 trial being conducted?
This trial is being conducted at Gloucester, United Kingdom.
Who is sponsoring the NCT07392684 clinical trial?
NCT07392684 is sponsored by Gloucestershire Hospitals NHS Foundation Trust. The trial plans to enroll 24 participants.